The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $33.10

Today's change-1.89 -5.40%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $33.10

Today's change-1.89 -5.40%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc crosses below 50-day moving average

Seattle Genetics Inc closed sharply lower Wednesday, dropping (U.S.)$1.89 or 5.40% to (U.S.)$33.10 and crossing below its 50-day moving average. Over the last five days, shares have lost 13.05% and are down 26.25% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $34.78
  • Previous close(U.S.) $34.99
  • High(U.S.) $35.05
  • Low(U.S.) $33.10
  • Bid / Ask(U.S.) $33.00 / (U.S.) $38.50
  • YTD % change-26.25%
  • Volume1,062,124
  • Average volume (10-day)880,845
  • Average volume (1-month)964,459
  • Average volume (3-month)1,246,534
  • 52-week range(U.S.) $26.02 to (U.S.) $52.33
  • Beta1.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.91
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue111938477
Total other revenue--------
Total revenue111938477
Gross profit102837469
Total cost of revenue1010109
Total operating expense132119111125
Selling / general / administrative30343030
Research & development93757186
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-21-25-27-48
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-25-26-48
Income after tax-20-25-26-48
Income tax, total--------
Net income-20-25-26-48
Total adjustments to net income--------
Net income before extra. items-20-25-26-48
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-25-26-48
Inc. avail. to common incl. extra. items-20-25-26-48
Diluted net income-20-25-26-48
Dilution adjustment--------
Diluted weighted average shares140140128125
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.18-0.21-0.38
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.15-0.18-0.21-0.38